(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDISCA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDISCA

ST13

US500000076229088

Class

1, 5, 35

Filing

76229088

Registration

2850060

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

08/20/2024

Trademark type

Word

Nice classes

1, 5, 35

Filing date

03/22/2001

Registration date

06/08/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/20/2024

Last transaction

08/20/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

1989-09-00

First use in commerce

1992-06-00

Drawing code

1

Owner type

03

Owner location

Saint-Laurent Quebec, CA

Examiner

ESTRADA,LINDA M

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MEDISCA PHARMACEUTIQUE INC.
MEDISCA PHARMACEUTIQUE INC.

Representatives

Douglas A. Rettew Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Technical classification

Nice Classes

Class 1Class 5Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Raw chemicals for use in compounding pharmaceutical medicines for human and veterinary use; active pharmaceutical ingredientsnamely chemicals for use in the manufacture of pharmaceuticals and medicines

Class 5

Controlled substancespharmaceutical preparations and narcotics for the treatment of various medical disease classificationsincluding dermatologicalgynecological and hormonal conditionsgeriatric and pediatric carechronic pain and palliative care managementinhalation therapy and infectious disease control for human and veterinary use

Class 35

Wholesale distributorship of electro-mechanical devicesprecision balances for weighinghot plates for melting homogenizersblending and stirring machinesshakers; wholesale distributorship of pharmaceutical chemicalswholesale distributorship of reusable and disposable containers; wholesale distributorship of measuring devices; wholesale distributorship of utensils for compounding pharmaceutical chemicals

Publications

History of USPTO decisions and trademark events.

56 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/20/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

08/20/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/20/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/20/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

06/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/28/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/28/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/28/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/28/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/28/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/08/2023

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

05/26/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/25/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/25/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/25/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/25/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/25/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/21/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/21/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/21/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/21/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/27/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/19/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/19/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/19/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/19/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

06/02/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/02/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/27/2010

CORV

REVIEW OF CORRESPONDENCE COMPLETE

09/27/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/17/2010

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

09/15/2010

E815

TEAS SECTION 8 & 15 RECEIVED

09/15/2010

CFIT

CASE FILE IN TICRS

06/08/2007

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/11/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

06/08/2004

PUBO

PUBLISHED FOR OPPOSITION

03/16/2004

NPUB

NOTICE OF PUBLICATION

02/25/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/15/2003

MAIL

PAPER RECEIVED

12/12/2003

CNEA

EXAMINERS AMENDMENT MAILED

12/05/2003

FAXX

FAX RECEIVED

12/01/2003

CNRT

NON-FINAL ACTION MAILED

06/11/2003

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/27/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/20/2002

CNEA

EXAMINERS AMENDMENT MAILED

12/18/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/07/2002

MAIL

PAPER RECEIVED

11/07/2002

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/23/2002

CNFR

FINAL REFUSAL MAILED

05/03/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/14/2002

UNPR

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

07/27/2001

CNRT

NON-FINAL ACTION MAILED

07/13/2001

DOCK

ASSIGNED TO EXAMINER

07/10/2001

Continuous trademark protection

Get notified about every new filing that threatens MEDISCA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.